Our Studies
Biomarkers
Innovative translational research uses biomarkers to accelerate or aid in diagnosis or monitoring and provide insight into “personalized” medicine.
A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological, pathogenic, or pharmacologic responses to a therapeutic intervention.
Learn more about enrolling in trials for Biomarkers.
Join A Study
A biomarker is a quantifiable biological parameter (such as blood pressure, heart rate, blood and genetic test, and x-rays) that are measured and evaluated over time as an indicator of normal biological, pathogenic, or pharmacologic responses to a therapeutic intervention.
Learn more about enrolling in trials for Biomarkers.
Biomarkers
Depression
Research and treatment options of depressive disorders in the chronic pain patient such as depression and anxiety.
Join A Study
Depression
Anxiety
Do you or someone you know have anxiety?
The SEP361-226 Study is looking at an investigational medication to see if it works in people with generalized anxiety disorder (GAD). The study will also look at how safe the investigational medication is and how the body reacts to it.
See if you qualify Today!
Join A Study
The SEP361-226 Study is looking at an investigational medication to see if it works in people with generalized anxiety disorder (GAD). The study will also look at how safe the investigational medication is and how the body reacts to it.
See if you qualify Today!
Anxiety
Memory Loss
Are you or a loved one experiencing memory loss? K2 Medical Research is currently enrolling for a new clinical research study that can potentially prevent or slow down the symptoms of Alzheimer’s disease.
Join A Study
Memory Loss
MOOD Study
Depression is a mental illness that causes prolonged feelings of sadness, hopelessness, and loss of interest in activities. It can affect daily functioning and physical health. Causes are a mix of genetic, environmental and psychological factors. Treatment options include therapy, medication, and lifestyle changes.
The MOOD Study is a prospective, multicenter, two-arm, double-blinded, randomized, controlled trial. MOOD will study the use of the Relivion platform technology in subjects suffering from major depressive disorder. You may qualify to participate in the MOOD Study sponsored by Neurolief. The target patient population is men and women ages 18-70 years old, who suffer from major depressive disorder.
See if you qualify Today!
Join A Study
The MOOD Study is a prospective, multicenter, two-arm, double-blinded, randomized, controlled trial. MOOD will study the use of the Relivion platform technology in subjects suffering from major depressive disorder. You may qualify to participate in the MOOD Study sponsored by Neurolief. The target patient population is men and women ages 18-70 years old, who suffer from major depressive disorder.
See if you qualify Today!
MOOD Study
Refer A Friend
At K2 Medical Research, we know that finding new devices, treatments, and cures is not a one-person job, that is why we need you to help spread the word about clinical trials. Our K2TrekTogether Referral Program is a referral program for family and friends to refer each other for clinical research trials. Qualified referrals will receive $50 per referral and there is no limit to the number of referrals.
Refer A Friend
Refer A Friend
Tomorrow’s treatment today.
Translate Language
Select A Location
